Z Squared Inc. (ZSQR) is the 121st largest of 213 Gene and Cell Therapy companies by market capitalisation, at 147.29 Mn, behind Tenaya Therapeutics, Inc. at 148.80 Mn. The table below compares all 213 on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | KRYS | Krystal Biotech, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 10.61 Bn | 43.92 | 24.07 | 9.76 Bn |
| 2 | CRSP | CRISPR Therapeutics AG | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 5.39 Bn | -11.15 | 402.57 | 5.39 Bn |
| 3 | LEGN | Legend Biotech Corp | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 3.97 Bn | -188.37 | 3.12 | 3.00 Bn |
| 4 | IOVA | Iovance Biotherapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 3.95 Bn | -18.92 | 12.17 | 3.66 Bn |
| 5 | BEAM | Beam Therapeutics Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 3.10 Bn | -36.27 | 19.86 | 3.10 Bn |
| 6 | QURE | uniQure N.V. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 2.95 Bn | -14.98 | 157.84 | 2.95 Bn |
| 7 | PGEN | Precigen, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 2.53 Bn | -7.52 | 29.54 | 2.53 Bn |
| 8 | SRPT | Sarepta Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 2.36 Bn | -17.23 | 1.20 | 1.57 Bn |
| 9 | MESO | Mesoblast Ltd | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 2.24 Bn | -38.60 | 18.46 | 2.14 Bn |
| 10 | TSHA | Taysha Gene Therapies, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 2.06 Bn | -13.80 | 376.45 | 2.06 Bn |
| 11 | VCEL | Vericel Corp | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 2.05 Bn | 81.70 | 6.69 | 1.89 Bn |
| 12 | NTLA | Intellia Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.70 Bn | -4.25 | 28.53 | 1.70 Bn |
| 13 | SLDB | Solid Biosciences Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.48 Bn | -7.27 | — | 1.48 Bn |
| 14 | MGTX | MeiraGTx Holdings plc | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.27 Bn | 7.69 | 3.17 | 1.13 Bn |
| 15 | IMTX | Immatics N.V. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.17 Bn | -4.85 | 24.04 | 0.71 Bn |
| 16 | SANA | Sana Biotechnology, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.14 Bn | -5.32 | — | 1.14 Bn |
| 17 | FDMT | 4D Molecular Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.05 Bn | -5.88 | 11.45 | 0.69 Bn |
| 18 | CADL | Candel Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.95 Bn | -14.49 | — | 0.95 Bn |
| 19 | IMMX | Immix Biopharma, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.89 Bn | -28.10 | — | 0.89 Bn |
| 20 | NGNE | Neurogene Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.86 Bn | -7.74 | — | 0.86 Bn |
| 21 | PRME | Prime Medicine, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.65 Bn | -3.48 | 160.56 | 0.65 Bn |
| 22 | ALLO | Allogene Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.65 Bn | -3.91 | 139.65 | 0.65 Bn |
| 23 | AUTL | Autolus Therapeutics plc | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.59 Bn | -2.32 | 5.31 | 0.39 Bn |
| 24 | BNTC | Benitec Biopharma Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.59 Bn | -12.72 | — | 0.59 Bn |
| 25 | CAPR | Capricor Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.54 Bn | -4.30 | — | 0.54 Bn |
| 26 | CABA | Cabaletta Bio, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.52 Bn | -2.85 | — | 0.52 Bn |
| 27 | KYTX | Kyverna Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.51 Bn | -3.31 | — | 0.51 Bn |
| 28 | RGNX | REGENXBIO Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.47 Bn | -2.67 | 2.50 | 0.37 Bn |
| 29 | OCGN | Ocugen, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.46 Bn | -5.61 | 100.20 | 0.36 Bn |
| 30 | IRD | Opus Genetics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.45 Bn | -4.60 | 45.34 | 0.36 Bn |
| 31 | ARTV | Artiva Biotherapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.44 Bn | -4.86 | — | 0.44 Bn |
| 32 | IPSC | Century Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.44 Bn | -4.01 | — | 0.18 Bn |
| 33 | RCKT | Rocket Pharmaceuticals, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.44 Bn | -25.35 | — | 0.44 Bn |
| 34 | LXEO | Lexeo Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.42 Bn | -4.80 | — | 0.42 Bn |
| 35 | PROK | Prokidney Corp. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.38 Bn | -2.84 | 464.12 | 0.38 Bn |
| 36 | ABEO | Abeona Therapeutics Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.34 Bn | -3.16 | 13.41 | 0.20 Bn |
| 37 | LYEL | Lyell Immunopharma, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.34 Bn | -1.36 | 12,443.49 | 0.34 Bn |
| 38 | CLLS | Cellectis S.A. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | -9.71 | 5.47 | 0.16 Bn |
| 39 | FATE | Fate Therapeutics Inc | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.30 Bn | -2.39 | 46.19 | 0.30 Bn |
| 40 | EDIT | Editas Medicine, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | — | — | 0.14 Bn |
| 41 | NWBO | Northwest Biotherapeutics Inc | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.28 Bn | -7.16 | 128.04 | 0.28 Bn |
| 42 | RNAC | Cartesian Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.27 Bn | -2.50 | 184.14 | 0.27 Bn |
| 43 | LCTX | Lineage Cell Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.27 Bn | -11.80 | 20.69 | 0.21 Bn |
| 44 | TARA | Protara Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.24 Bn | -3.43 | — | 0.24 Bn |
| 45 | NKTX | Nkarta, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | -1.52 | — | 0.22 Bn |
| 46 | VYGR | Voyager Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.21 Bn | -2.56 | 6.11 | 0.09 Bn |
| 47 | DTIL | Precision Biosciences Inc | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -5.69 | 4.29 | 0.11 Bn |
| 48 | CRBU | Caribou Biosciences, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.16 Bn | -1.44 | 15.70 | 0.05 Bn |
| 49 | TNYA | Tenaya Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.15 Bn | -1.44 | 111.46 | 0.15 Bn |
| 50 | ZSQR | Z Squared Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.15 Bn | -7.64 | 52.66 | 0.13 Bn |
| 51 | ATRA | Atara Biotherapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.15 Bn | -6.25 | 23.71 | 0.13 Bn |
| 52 | HUMA | Humacyte, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | -1.18 | 66.64 | 0.14 Bn |
| 53 | ENGN | enGene Therapeutics Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.13 Bn | -1.00 | — | 0.13 Bn |
| 54 | ACET | Adicet Bio, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -1.04 | — | -0.02 Bn |
| 55 | ANIX | Anixa Biosciences Inc | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -9.92 | — | 0.10 Bn |
| 56 | INMB | Inmune Bio, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | -3.18 | — | 0.05 Bn |
| 57 | INKT | MiNK Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | -5.00 | — | 0.06 Bn |
| 58 | APTN | Adaptin Bio, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | -10.22 | — | 0.06 Bn |
| 59 | TCRX | TScan Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -0.44 | 7.27 | 0.05 Bn |
| 60 | SGMOQ | Sangamo Therapeutics, Inc | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.36 | 1.13 | 0.02 Bn |
| 61 | CELU | Celularity Inc | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.48 | 1.66 | 0.04 Bn |
| 62 | MGX | Metagenomi Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.47 | 2.02 | 0.04 Bn |
| 63 | ESLA | Estrella Immunopharma, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -3.79 | — | 0.03 Bn |
| 64 | TVGN | Tevogen Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -1.21 | — | 0.03 Bn |
| 65 | INAB | In8Bio, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.29 | — | 0.02 Bn |
| 66 | MRKR | Marker Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -2.26 | — | 0.01 Bn |
| 67 | LGVN | Longeveron Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.91 | 18.17 | 0.01 Bn |
| 68 | GNTA | Genenta Science S.p.A. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -3.83 | — | -0.01 Bn |
| 69 | PASG | Passage BIO, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.39 | — | 0.02 Bn |
| 70 | ADIA | Adia Nutrition, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -75.51 | 69.62 | 0.01 Bn |
| 71 | PLUR | Pluri Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | 0.00 | 9.06 | 0.00 Bn |
| 72 | FBLG | FibroBiologics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.67 | — | 0.01 Bn |
| 73 | SNTI | Senti Biosciences Holdings, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.16 | 622.71 | 0.01 Bn |
| 74 | GDTC | CytoMed Therapeutics Ltd | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -3.36 | 41.92 | 0.01 Bn |
| 75 | ZEOX | Zeo ScientifiX, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -2.21 | 1.34 | 0.01 Bn |
| 76 | LNAI | Lunai Bioworks Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.05 | 86.37 | 0.00 Bn |
| 77 | TPST | Tempest Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.28 | — | 0.00 Bn |
| 78 | PMCB | PharmaCyte Biotech, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.18 | — | 0.00 Bn |
| 79 | MBIO | Mustang Bio, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.20 | — | 0.00 Bn |
| 80 | ISCO | International Stem Cell CORP | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -9.66 | 0.32 | 0.00 Bn |
| 81 | CLDI | Calidi Biotherapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.08 | — | 0.00 Bn |
| 82 | GNPX | Genprex, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | -0.01 Bn |
| 83 | CELZ | Creative Medical Technology Holdings, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.21 | 517.47 | 0.00 Bn |
| 84 | RMTG | Regenerative Medical Technology Group Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.11 | 0.12 | 0.00 Bn |
| 85 | ERNAW | Ernexa Therapeutics Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.01 | — | 0.00 Bn |
| 86 | BRTX | BioRestorative Therapies, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | 0.00 | 0.18 | 0.00 Bn |
| 87 | JNJ | Johnson & Johnson | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 663.34 Bn | 31.53 | 6.77 | 642.58 Bn |
| 88 | TMO | Thermo Fisher Scientific Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 226.66 Bn | 32.20 | 4.89 | 222.59 Bn |
| 89 | ABT | Abbott Laboratories | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 188.53 Bn | 34.75 | 4.05 | 182.93 Bn |
| 90 | GILD | Gilead Sciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 187.36 Bn | -64.72 | 6.15 | 184.18 Bn |
| 91 | DHR | Danaher Corp /De/ | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 146.26 Bn | 36.66 | 5.83 | 141.91 Bn |
| 92 | VRTX | Vertex Pharmaceuticals Inc / Ma | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 138.47 Bn | 31.43 | 11.00 | 130.62 Bn |
| 93 | ISRG | Intuitive Surgical Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 129.80 Bn | 41.10 | 11.76 | 124.58 Bn |
| 94 | MDT | Medtronic plc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 120.89 Bn | 24.99 | 3.32 | 111.67 Bn |
| 95 | CAH | Cardinal Health Inc | secondary | H-19 | Healthcare Payers and Distributors | HG-05 | 58.29 Bn | 34.19 | 0.23 | 53.43 Bn |
| 96 | BDX | Becton Dickinson & Co | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 50.76 Bn | 53.89 | 2.18 | 49.90 Bn |
| 97 | A | Agilent Technologies, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 42.45 Bn | 29.48 | 5.76 | 40.69 Bn |
| 98 | IDXX | Idexx Laboratories Inc /De | secondary | H-05 | Pharmaceuticals and Biotechnology | HG-01 | 42.28 Bn | 37.10 | 9.29 | 42.08 Bn |
| 99 | ILMN | Illumina, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 32.98 Bn | 39.98 | 7.34 | 31.81 Bn |
| 100 | MDLN | Medline Inc. | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 31.33 Bn | 30.33 | 1.10 | 28.65 Bn |
| 101 | GEHC | GE HealthCare Technologies Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 31.19 Bn | 15.21 | 1.47 | 29.09 Bn |
| 102 | INSM | INSMED Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 27.48 Bn | -31.39 | 24.15 | 26.32 Bn |
| 103 | ROIV | Roivant Sciences Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 25.18 Bn | -16.97 | 2,305.26 | 25.18 Bn |
| 104 | UTHR | UNITED THERAPEUTICS Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 20.83 Bn | 15.89 | 6.60 | 18.16 Bn |
| 105 | FTV | Fortive Corp | secondary | I-04 | Machinery | IG-02 | 17.33 Bn | 32.42 | 4.01 | 16.95 Bn |
| 106 | NBIX | Neurocrine Biosciences Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.76 Bn | 22.33 | 4.67 | 15.37 Bn |
| 107 | RVTY | Revvity, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 14.52 Bn | 61.12 | 4.99 | 13.50 Bn |
| 108 | COO | Cooper Companies, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 13.56 Bn | 57.52 | 3.21 | 13.43 Bn |
| 109 | BAX | Baxter International Inc | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 13.36 Bn | 580.95 | 1.20 | 11.21 Bn |
| 110 | BMRN | Biomarin Pharmaceutical Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 12.88 Bn | 176.51 | 3.78 | 12.01 Bn |
| 111 | TECH | BIO-TECHNE Corp | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 11.29 Bn | 62.10 | 9.30 | 11.03 Bn |
| 112 | BIO | Bio-Rad Laboratories, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 10.32 Bn | 46.38 | 3.98 | 8.70 Bn |
| 113 | BRKR | Bruker Corp | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 8.89 Bn | -83.19 | 2.54 | 8.89 Bn |
| 114 | IBRX | ImmunityBio, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 8.51 Bn | -8.58 | 51.33 | 8.15 Bn |
| 115 | TGTX | Tg Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 7.97 Bn | 18.05 | 9.97 | 7.29 Bn |
| 116 | OKLO | Oklo Inc. | secondary | U-03 | Power Generation | UG-01 | 7.27 Bn | -47.56 | 6,095.74 | 7.27 Bn |
| 117 | LNTH | Lantheus Holdings, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 6.58 Bn | 23.89 | 4.23 | 5.98 Bn |
| 118 | MMED | MiniMed Group, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 5.98 Bn | -12.68 | 1.97 | 5.69 Bn |
| 119 | STVN | Stevanato Group S.p.A. | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 5.57 Bn | 35.48 | 3.90 | 5.46 Bn |
| 120 | GRFS | Grifols SA | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.31 Bn | 20.91 | 0.32 | 4.15 Bn |
| 121 | RADX | Radiopharm Theranostics Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.33 Bn | -58.78 | 20,980.03 | 4.33 Bn |
| 122 | HTFL | Heartflow, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 4.24 Bn | -174.83 | 20.91 | 3.87 Bn |
| 123 | MIR | Mirion Technologies, Inc. | secondary | I-39 | Clean Energy Equipment | IG-10 | 4.16 Bn | 162.60 | 4.06 | 3.74 Bn |
| 124 | TLX | Telix Pharmaceuticals Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.03 Bn | — | — | 3.74 Bn |
| 125 | GRAL | GRAIL, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 3.46 Bn | -8.85 | 22.03 | 2.60 Bn |
| 126 | VCYT | Veracyte, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 3.41 Bn | 29.81 | 6.07 | 3.11 Bn |
| 127 | OSIS | Osi Systems Inc | secondary | I-02 | Aerospace and Defense | IG-01 | 3.38 Bn | 21.85 | 1.89 | 3.02 Bn |
| 128 | SXI | Standex International Corp/De/ | secondary | I-04 | Machinery | IG-02 | 3.32 Bn | 25.81 | 3.72 | 3.14 Bn |
| 129 | CDNA | CareDx, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 2.61 Bn | 23.56 | 5.71 | 2.24 Bn |
| 130 | NEOG | Neogen Corp | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 2.58 Bn | -363.57 | 2.96 | 2.39 Bn |
| 131 | BFLY | Butterfly Network, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 1.93 Bn | -25.72 | 17.17 | 1.80 Bn |
| 132 | LKFT | Lakefront Biotherapeutics NV | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.88 Bn | 0.01 | 1.63 | 1.88 Bn |
| 133 | RARE | Ultragenyx Pharmaceutical Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.56 Bn | -3.38 | 2.18 | 1.27 Bn |
| 134 | ATEC | Alphatec Holdings, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.48 Bn | -13.47 | 1.82 | 1.36 Bn |
| 135 | ASST | Strive, Inc. | secondary | F-09 | Asset and Wealth Management | FG-03 | 1.19 Bn | -3.01 | 4,580.20 | 1.12 Bn |
| 136 | PCRX | Pacira BioSciences, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.04 Bn | 71.36 | 1.40 | 0.79 Bn |
| 137 | QDEL | QuidelOrtho Corp | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.95 Bn | — | — | 0.83 Bn |
| 138 | CBLL | Ceribell, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.94 Bn | -14.26 | 9.23 | 0.81 Bn |
| 139 | VREX | Varex Imaging Corp | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.78 Bn | 34.63 | 0.90 | 0.68 Bn |
| 140 | MLAB | Mesa Laboratories Inc /Co/ | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.72 Bn | 204.88 | 2.89 | 0.69 Bn |
| 141 | CTKB | Cytek Biosciences, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.61 Bn | -7.57 | 2.95 | 0.54 Bn |
| 142 | NEUP | Neuphoria Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.47 Bn | -19.80 | — | 0.45 Bn |
| 143 | CATX | Perspective Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.38 Bn | -3.18 | — | 0.38 Bn |
| 144 | TKNO | Alpha Teknova, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.37 Bn | -28.17 | 8.46 | 0.35 Bn |
| 145 | PRE | Prenetics Global Ltd | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.36 Bn | -11.08 | 2.56 | 0.30 Bn |
| 146 | AGEN | Agenus Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.34 Bn | 3.73 | 2.58 | 0.34 Bn |
| 147 | MYGN | Myriad Genetics Inc | secondary | H-17 | Healthcare Providers | HG-04 | 0.30 Bn | -2.68 | 0.37 | 0.19 Bn |
| 148 | CV | CapsoVision, Inc | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.30 Bn | -10.98 | 20.89 | 0.29 Bn |
| 149 | BCYC | Bicycle Therapeutics Plc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.30 Bn | -1.57 | 4.90 | 0.30 Bn |
| 150 | ACIU | AC Immune SA | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | 8.48 | 12.87 | 0.29 Bn |
| 151 | NNNN | Anbio Biotechnology | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.28 Bn | 45.01 | 109.83 | 0.27 Bn |
| 152 | CELG-RI | Bristol Myers Squibb Co | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.28 Bn | 0.03 | 0.01 | -10.79 Bn |
| 153 | ALEC | Alector, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.27 Bn | -3.11 | 19.66 | 0.10 Bn |
| 154 | OSUR | Orasure Technologies Inc | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.25 Bn | — | 2,540.54 | 0.05 Bn |
| 155 | RELL | Richardson Electronics, Ltd. | secondary | I-07 | Machinery | IG-02 | 0.25 Bn | 42.51 | 1.10 | 0.22 Bn |
| 156 | LUCD | Lucid Diagnostics Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 0.17 Bn | -2.64 | 31.17 | 0.14 Bn |
| 157 | IMDX | Insight Molecular Diagnostics Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.15 Bn | -2.80 | 91.10 | 0.13 Bn |
| 158 | HURA | TuHURA Biosciences, Inc./NV | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | -4.47 | — | 0.14 Bn |
| 159 | GUTS | Fractyl Health, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.11 Bn | -0.86 | — | 0.11 Bn |
| 160 | BNR | Burning Rock Biotech Ltd | secondary | H-17 | Healthcare Providers | HG-04 | 0.11 Bn | -12.72 | 1.40 | 0.04 Bn |
| 161 | SERA | Sera Prognostics, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 0.10 Bn | -3.05 | 1,456.62 | 0.10 Bn |
| 162 | PLYX | Polaryx Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -9.70 | — | 0.09 Bn |
| 163 | LUNG | Pulmonx Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.09 Bn | — | — | 0.02 Bn |
| 164 | ICCC | Immucell Corp /De/ | secondary | H-05 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -210.18 | 3.34 | 0.08 Bn |
| 165 | FBIO | Fortress Biotech, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | 10.39 | 1.26 | -0.11 Bn |
| 166 | HYPR | Hyperfine, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.08 Bn | -2.34 | 4.93 | 0.04 Bn |
| 167 | RTGN | RetinalGenix Technologies Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.08 Bn | — | — | 0.08 Bn |
| 168 | RPID | Rapid Micro Biosystems, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.06 Bn | -1.26 | 1.83 | 0.04 Bn |
| 169 | NNOX | Nano-X Imaging Ltd. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.05 Bn | -0.68 | 3.73 | 0.01 Bn |
| 170 | MDAI | Spectral AI, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.05 Bn | -5.95 | 3.28 | 0.04 Bn |
| 171 | PRPO | Precipio, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 0.05 Bn | 158.79 | 0.83 | 0.04 Bn |
| 172 | SER | Serina Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -1.57 | 341.56 | 0.02 Bn |
| 173 | PAVM | PAVmed Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.03 Bn | -1.23 | 264.82 | 0.03 Bn |
| 174 | ARAY | Accuray Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.03 Bn | -0.67 | 0.08 | -0.01 Bn |
| 175 | ADIL | Adial Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -0.52 | — | 0.03 Bn |
| 176 | ATNM | Actinium Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | 2.86 | 0.92 | 0.03 Bn |
| 177 | QUCY | Quantum Cyber N.V. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.03 Bn | -1.15 | — | 0.01 Bn |
| 178 | GIPL | Global Innovative Platforms Inc. | secondary | H-05 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -36.02 | 132.88 | 0.02 Bn |
| 179 | QTEX | QTREX Quantum Ltd. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.02 Bn | 1.84 | 4.40 | 0.02 Bn |
| 180 | AIFF | Firefly Neuroscience, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.02 Bn | -2.42 | 12.70 | 0.01 Bn |
| 181 | ALLR | Allarity Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.87 | 903.73 | 0.02 Bn |
| 182 | BEAT | HeartBeam, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.02 Bn | -1.40 | — | 0.02 Bn |
| 183 | PLSM | Pulsenmore Ltd. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.02 Bn | 8.23 | 13.89 | -0.01 Bn |
| 184 | CTXR | Citius Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.33 | 2.15 | 0.02 Bn |
| 185 | NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | -1.91 | 1.50 | 0.01 Bn |
| 186 | ALRTF | ALR Technologies SG Ltd. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | 0.55 | — | 0.01 Bn |
| 187 | ASTC | ASTROTECH Corp | secondary | I-04 | Machinery | IG-02 | 0.01 Bn | -0.88 | 12.21 | 0.01 Bn |
| 188 | ADVB | Advanced Biomed Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | 2.68 | — | 0.01 Bn |
| 189 | FEMY | Femasys Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | -0.50 | 6.04 | 0.01 Bn |
| 190 | HSCS | HeartSciences Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | -1.06 | 1,132.67 | 0.01 Bn |
| 191 | NDRA | ENDRA Life Sciences Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | -1.38 | — | 0.00 Bn |
| 192 | BMRA | Biomerica Inc | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | -2.25 | 1.51 | 0.01 Bn |
| 193 | AIDX | 20/20 Biolabs, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 0.01 Bn | -0.98 | 2.94 | 0.00 Bn |
| 194 | TRIB | Trinity Biotech Plc | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | -0.17 | 0.14 | 0.00 Bn |
| 195 | ACON | Aclarion, Inc. | secondary | T-27 | Vertical Software | TG-05 | 0.01 Bn | -0.63 | 69.66 | 0.01 Bn |
| 196 | MBAI | Check-Cap Ltd | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | 1.22 | 2.72 | 0.00 Bn |
| 197 | CDIO | Cardio Diagnostics Holdings, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | -0.84 | 376.85 | 0.00 Bn |
| 198 | VVOS | Vivos Therapeutics, Inc. | secondary | H-09 | Medical Devices and Diagnostics | HG-02 | 0.00 Bn | -0.13 | 0.16 | 0.00 Bn |
| 199 | INBS | Intelligent Bio Solutions Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.00 Bn | -0.26 | 0.77 | 0.00 Bn |
| 200 | AVCRF | Avricore Health Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.00 Bn | -2.33 | 7.20 | 0.00 Bn |
| 201 | CASIF | CASI Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.02 | 0.12 | 0.00 Bn |
| 202 | GOVX | GeoVax Labs, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.11 | 2.67 | 0.00 Bn |
| 203 | ONCO | Onconetix, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.00 Bn | -0.21 | 3.29 | 0.00 Bn |
| 204 | RNAZ | Transcode Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.04 | — | 0.00 Bn |
| 205 | BCAB | BioAtla, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.06 | 0.24 | 0.00 Bn |
| 206 | AMIX | Autonomix Medical, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.00 Bn | — | — | -0.01 Bn |
| 207 | BJDX | Bluejay Diagnostics, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.00 Bn | -0.24 | — | 0.00 Bn |
| 208 | LUDG | Ludwig Enterprises, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 0.00 Bn | -1.11 | — | 0.00 Bn |
| 209 | VNRX | Volitionrx Ltd | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.00 Bn | -0.09 | 0.65 | 0.00 Bn |
| 210 | VRAX | Virax Biolabs Group Ltd | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.00 Bn | 0.19 | 81.93 | -0.01 Bn |
| 211 | WOK | WORK Medical Technology Group LTD | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 0.00 Bn | — | — | 0.00 Bn |
| 212 | GRMLW | Greenland Mines Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.02 | — | -0.01 Bn |
| 213 | ADTX | Aditxt, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | 0.00 | 0.01 | 0.00 Bn |